It should be noted that in breast cancer, ADAR-mediated RNA editing promotes tumor progression, whereas in hepatocellular carcinoma, ADAR1 contributes to increased cell proliferation by editing AZIN1 mRNA [147]. Here, ADAR is linked to neoplasm.